Insider Transactions in Q1 2024 at Anavex Life Sciences Corp. (AVXL)
Insider Transaction List (Q1 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 28
2024
|
Christopher U Missling President and CEO |
SELL
Open market or private sale
|
Direct |
73,380
-5.54%
|
$366,900
$5.11 P/Share
|
Mar 28
2024
|
Christopher U Missling President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
73,380
+5.25%
|
$73,380
$1.32 P/Share
|